About Emilie-Marie Vieuble

This author has not yet filled in any details.
So far Emilie-Marie Vieuble has created 139 blog entries.

Why invest in clinical research? Benefits of conducting research with an experienced CRO

In the last years, there has been an increasing demand from consumers to understand how a health-enhancing product works and provides its benefits. As technology evolves and consumers gain better understanding of medical knowledge, brands will benefit from scientifically and clinically substantiated products. As a consequence, food business operators (FBO) are being challenged to [...]

Why invest in clinical research? Benefits of conducting research with an experienced CRO2019-12-10T09:58:05+01:00

NEWS DIGEST by a&r | November 2019

We dedicate this November issue to the importance of clinical research in the field of natural health products. Also, we announce our first free webinar for 2020; it is going to be about substance-based medical devices under MDR. […]

NEWS DIGEST by a&r | November 20192020-01-29T13:43:26+01:00

MDR – A new Corrigendum on the way?

The EU Medical Devices Regulation (MDR, 2017/745), which came into force in May 2017, must be implemented by 26th May 2020. So far, only five Notified Bodies are able to certify products under the new regulation. As far as we know, only two products have been CE certified under MDR, one being BSI for [...]

MDR – A new Corrigendum on the way?2019-11-05T15:46:38+01:00

Plant-based protein – the protein paradigm shift

In the food sector, plant proteins are widely used both in conventional and in organic markets. Although animal protein consumption is increasing at global level, the EU is seeing the emergence of low animal protein diets. Recent changes across some EU countries suggest the beginning of a shift back towards plants and to less [...]

Plant-based protein – the protein paradigm shift2019-11-05T14:42:15+01:00

Negative feedback from EFSA on the safety of leaf powder of Moringa stenopetala and of powder or juice concentrate of berries of Aristotelia chilensis

Following a notification of leaf powder of Moringa stenopetala as a traditional food from a third country pursuant to Article 14 of Regulation (EU) 2015/2283 (Novel Food Regulation), EFSA was asked by the European Commission whether there are safety objections to the notification. EFSA found, due to the lack of information regarding the quality [...]

Negative feedback from EFSA on the safety of leaf powder of Moringa stenopetala and of powder or juice concentrate of berries of Aristotelia chilensis2019-10-01T12:41:12+02:00

End of a decade – EFSA ends update for DRVs of 34 nutrients

For the last 10 years, EFSA has been evaluating/updating the values for macronutrients such as proteins and carbohydrates, as well as 14 vitamins and 13 minerals. EFSA’s latest scientific opinion about dietary reference values (DRVs) was published this month, setting the DRVs for sodium and chloride. DRVs is an umbrella term for science-based nutrient reference values for [...]

End of a decade – EFSA ends update for DRVs of 34 nutrients2019-10-01T12:27:08+02:00

NEWS DIGEST by a&r | September 2019

We dedicate this September issue to the end of EFSA’s evaluation of Dietary Reference Values (DRVs) for macronutrients and two safety objections by EFSA for traditional foods from a third country. […]

NEWS DIGEST by a&r | September 20192019-10-01T16:20:18+02:00

Act now and get the most of it! Keep your substance-based medical devices in your portfolio with the support of analyze & realize

Background – What changed from MDD to MDR? What are the main implications for substance-based medical devices? In May 2017, the Medical Device Regulation (EU) 2017/745 (MDR) entered into force, replacing the old Medical Decide Directive (MDD; 93/42/EEC medical devices). So theoretically, for a time period of 3 years following the entry into force [...]

Act now and get the most of it! Keep your substance-based medical devices in your portfolio with the support of analyze & realize2019-09-03T10:26:06+02:00